Élie Haddad - Infectious Diseases

Author Information

Élie Haddad is a distinguished researcher affiliated with the Infectious and Tropical Diseases Department at Pitié-Salpêtrière Charles Foix University Hospitals, part of Sorbonne University, AP-HP, located in Paris, France. His research spans various aspects of infectious diseases, with significant contributions to understanding complex conditions and therapeutic interventions. Dr. Haddad's work is integral to advancing medical knowledge and treatment strategies in his field.

Research Contributions

Dr. Élie Haddad has an extensive research portfolio with a focus on infectious diseases and immunology. His recent studies include exploring therapeutic vulnerabilities in acute lymphoblastic leukemia through genome-wide CRISPR screens, investigating the role of stress signals in multiple sclerosis, and examining dynamic interactions between T lymphocytes and human neural cells. Additionally, his work on antibiotic usage in COVID-19 treatment and case studies on conditions like brain abscesses and brucellosis highlight his commitment to addressing pressing healthcare challenges. Dr. Haddad's research aids in improving patient outcomes through innovative approaches and interdisciplinary collaboration.

Aliases

Dr. Élie Haddad is also known by several aliases including E Haddad, E. Haddad, and Elie Haddad. These variations may appear in different publications or databases.

Publication and Citation Metrics

Metric	Value
Total Papers	243
Total Citations	8734
H-index	47

Publications:

Autologous humanized mouse models of iPSC-derived tumors enable characterization and modulation of cancer-immune cell interactions

DOI: 10.1016/j.crmeth.2021.100153

Year: 2022

Genome-wide CRISPR Screens Identify Ferroptosis as a Novel Therapeutic Vulnerability in Acute Lymphoblastic Leukemia

DOI: 10.1101/2022.02.01.478478

Year: 2022

A case series of brain abscesses: an eleven-year retrospective single center study.

DOI: 10.3855/jidc.12816

Year: 2021

Refractory pruritus responds to dupilumab in a patient with TTC7A mutation

DOI: 10.1016/j.jdcr.2020.12.004

Year: 2021

French-language adaptation of the 16D and 17D Quality of Life measures and score description in two Canadian pediatric samples

DOI: 10.1080/21642850.2021.1948416

Year: 2021

CD5 levels define functionally heterogeneous populations of naïve human CD4+ T cells

DOI: 10.1002/eji.202048788

Year: 2021

Stress Signal ULBP4, an NKG2D Ligand, Is Upregulated in Multiple Sclerosis and Shapes CD8+ T-Cell Behaviors

DOI: 10.1212/NXI.0000000000001119

Year: 2021

Capturing T Lymphocytes’ Dynamic Interactions With Human Neural Cells Using Time-Lapse Microscopy

DOI: 10.3389/fimmu.2021.668483

Year: 2021

Antibiotic usage in 2019 coronavirus disease (Covid-19) treatment: a rapid review on frequency, indications, and efficacy

DOI: 10.1016/j.jiph.2021.02.001

Year: 2021

Brucella pelvic tubo-ovarian abscess with a history of chronic brucellosis

DOI: 10.1016/j.idcr.2020.e01029

Year: 2021

How Does Viral Interference Occur?

How Does the FDA Ensure the Safety of Antiviral Drugs?

What is the Prognosis for Infected Individuals?

What is Malaria?

Can Targeting Metabolic Pathways Serve as a Therapeutic Strategy?

What is Inherited Immunity?

How Can We Target the Apicoplast for Treatment?

What is the Importance of Respiratory Hygiene?

What is the Role of Genomics in Tracking Disease Outbreaks?

What Does the Future Hold?

Partnered Content Networks

Relevant Topics